NEVVI Medicare utilization intelligence
or

← back

Provider profile

JACOBS, DANIEL M.D.

Neurology · NPI 1356323166 · ORLANDO, FL

3
Groups
17
Codes · 2024
19,275
Disclosed services

JACOBS, DANIEL is a Neurology in ORLANDO, FL, a member of 3 medical groups, who billed 17 distinct codes to Medicare Part B in 2024.

Groups: ABILITY HEALTH SERVICES AND REHABILITATION LP (SANFORD, FL) · ABILITY HEALTH SERVICES, INC (SANFORD, FL) · NEUROLOGICAL SERVICES OF ORLANDO PA (ORLANDO, FL) — member of 3 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

19,275
disclosed services
17
codes billed to Medicare Part B
Prior year · CY2023 15,986 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J2350 Injection, ocrelizumab, 1 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
95886 Needle measurement of electrical activity in arm or leg muscles, complete study
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
95912 Nerve conduction, 11-12 studies
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
95819 Measurement of brain wave activity (eeg), awake and asleep
95911 Nerve conduction, 9-10 studies
99443 Telephone medical discussion with physician, 21-30 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.